AAAAAA
Results: 176-200/790
Authors:
Folsom, AR
Citation: Ar. Folsom, Fibrinolytic factors and atherothrombotic events: epidemiological evidence, ANN MED, 32, 2000, pp. 85-91
Authors:
Kendrick, T
Citation: T. Kendrick, Primary care options to prevent mental illness, ANN MED, 31(6), 1999, pp. 359-363
Authors:
Swarte, NB
Heintz, APM
Citation: Nb. Swarte et Apm. Heintz, Euthanasia and physician-assisted suicide, ANN MED, 31(6), 1999, pp. 364-371
Authors:
Hankin, BL
Abramson, LY
Citation: Bl. Hankin et Ly. Abramson, Development of gender differences in depression: description and possible explanations, ANN MED, 31(6), 1999, pp. 372-379
Authors:
Hasegawa, I
Hayashi, T
Miyashita, Y
Citation: I. Hasegawa et al., Memory retrieval under the control of the prefrontal cortex, ANN MED, 31(6), 1999, pp. 380-387
Authors:
Manecke, RG
Mulhall, JP
Citation: Rg. Manecke et Jp. Mulhall, Medical treatment of erectile dysfunction, ANN MED, 31(6), 1999, pp. 388-398
Authors:
Collin, P
Citation: P. Collin, New diagnostic findings in coeliac disease, ANN MED, 31(6), 1999, pp. 399-405
Authors:
Davies, NP
Hanna, MG
Citation: Np. Davies et Mg. Hanna, Neurological channelopathies: diagnosis and therapy in the new millennium, ANN MED, 31(6), 1999, pp. 406-420
Authors:
Wildner, O
Citation: O. Wildner, In situ use of suicide genes for therapy of brain tumours, ANN MED, 31(6), 1999, pp. 421-429
Authors:
Scheinin, H
Knuuti, J
Scheinin, M
Citation: H. Scheinin et al., PET in drug discovery and development: an introduction, ANN MED, 31(6), 1999, pp. 430-431
Authors:
Vaalburg, W
Hendrikse, NH
de Vries, EFJ
Citation: W. Vaalburg et al., Drug development, radiolabelled drugs and PET, ANN MED, 31(6), 1999, pp. 432-437
Authors:
Hietala, J
Citation: J. Hietala, Ligand-receptor interactions studied by PET: implications for drug development, ANN MED, 31(6), 1999, pp. 438-443
Authors:
Rinne, JO
Citation: Jo. Rinne, Drug development for neurodegenerative diseases: role of PET, ANN MED, 31(6), 1999, pp. 444-449
Authors:
Knuuti, J
Nuutila, P
Citation: J. Knuuti et P. Nuutila, PET as a cardiovascular and metabolic research tool, ANN MED, 31(6), 1999, pp. 450-456
Authors:
Sela, S
Barzilai, A
Citation: S. Sela et A. Barzilai, Why do we fail with penicillin in the treatment of group A streptococcus infections?, ANN MED, 31(5), 1999, pp. 303-307
Authors:
Lo, YMD
Citation: Ymd. Lo, Fetal RhD genotyping from maternal plasma, ANN MED, 31(5), 1999, pp. 308-312
Authors:
Silagy, CA
Campion, K
Citation: Ca. Silagy et K. Campion, Effectiveness and role of zanamivir in the treatment of influenza infection, ANN MED, 31(5), 1999, pp. 313-317
Authors:
Niittynen, L
Nurminen, ML
Korpela, R
Vapaatalo, H
Citation: L. Niittynen et al., Role of arginine, taurine and homocysteine in cardiovascular diseases, ANN MED, 31(5), 1999, pp. 318-326
Authors:
Richardson, MD
Kokki, MH
Citation: Md. Richardson et Mh. Kokki, New perspectives in the diagnosis of systemic fungal infections, ANN MED, 31(5), 1999, pp. 327-335
Authors:
Ellis, PM
Tattersall, MHN
Citation: Pm. Ellis et Mhn. Tattersall, How should doctors communicate the diagnosis of cancer to patients?, ANN MED, 31(5), 1999, pp. 336-341
Authors:
Rocchi, S
Auwerx, J
Citation: S. Rocchi et J. Auwerx, Peroxisome proliferator-activated receptor-gamma: a versatile metabolic regulator, ANN MED, 31(5), 1999, pp. 342-351
Authors:
Horcajada, JP
Garcia-Bengoechea, M
Cilla, G
Etxaniz, P
Cuadrado, E
Arenas, JI
Citation: Jp. Horcajada et al., Mixed cryoglobulinaemia in patients with chronic hepatitis C infection: prevalence, significance and relationship with different viral genotypes, ANN MED, 31(5), 1999, pp. 352-358
Authors:
Wahlberg, P
Citation: P. Wahlberg, Vaccination against Lyme borreliosis, ANN MED, 31(4), 1999, pp. 233-235
Authors:
Vanhala, M
Citation: M. Vanhala, Childhood weight and metabolic syndrome in adults, ANN MED, 31(4), 1999, pp. 236-239
Authors:
Airaksinen, KEJ
Citation: Kej. Airaksinen, Autonomic mechanisms and sudden death after abrupt coronary occlusion, ANN MED, 31(4), 1999, pp. 240-245